• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Full methylation of H3K27 by PRC2 is dispensable for initial embryoid body formation but required to maintain differentiated cell identity.PRC2 介导的 H3K27 完全甲基化对于初始胚体形成不是必需的,但对于维持分化细胞的身份是必需的。
Development. 2021 Apr 1;148(7). doi: 10.1242/dev.196329. Epub 2021 Apr 15.
2
Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.解析 H3K27 乙酰化和甲基化在 PRC2 介导的细胞身份控制中的作用。
Nat Commun. 2019 Apr 11;10(1):1679. doi: 10.1038/s41467-019-09624-w.
3
EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.EZH2 变体在组蛋白甲基化和细胞分化中差异调节多梳抑制复合物 2。
Epigenetics Chromatin. 2018 Dec 6;11(1):71. doi: 10.1186/s13072-018-0242-9.
4
Regulation of histone methylation by automethylation of PRC2.PRC2 的自身甲基化对组蛋白甲基化的调控。
Genes Dev. 2019 Oct 1;33(19-20):1416-1427. doi: 10.1101/gad.328849.119. Epub 2019 Sep 5.
5
Roles of H3K27me2 and H3K27me3 Examined during Fate Specification of Embryonic Stem Cells.在胚胎干细胞命运特化过程中对H3K27me2和H3K27me3作用的研究
Cell Rep. 2016 Oct 25;17(5):1369-1382. doi: 10.1016/j.celrep.2016.09.087.
6
Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2.不同的刺激机制调节 Polycomb 抑制复合物 2 的催化活性。
Mol Cell. 2018 May 3;70(3):435-448.e5. doi: 10.1016/j.molcel.2018.03.019. Epub 2018 Apr 19.
7
Polycomb protein EED is required for silencing of pluripotency genes upon ESC differentiation.多梳蛋白 EED 对于 ESC 分化时多能性基因的沉默是必需的。
Stem Cell Rev Rep. 2015 Feb;11(1):50-61. doi: 10.1007/s12015-014-9550-z.
8
Polycomb Repressive Complex 2 Methylates Elongin A to Regulate Transcription.多梳抑制复合物2使延伸因子A甲基化以调控转录。
Mol Cell. 2017 Dec 7;68(5):872-884.e6. doi: 10.1016/j.molcel.2017.10.025. Epub 2017 Nov 16.
9
Accurate H3K27 methylation can be established de novo by SUZ12-directed PRC2.准确的 H3K27 甲基化可以由 SUZ12 定向的 PRC2 从头建立。
Nat Struct Mol Biol. 2018 Mar;25(3):225-232. doi: 10.1038/s41594-018-0036-6. Epub 2018 Feb 26.
10
EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.EZH1介导组蛋白H3赖氨酸27的甲基化,并在维持干细胞特性和执行多能性方面补充EZH2的功能。
Mol Cell. 2008 Nov 21;32(4):491-502. doi: 10.1016/j.molcel.2008.10.016.

引用本文的文献

1
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).组蛋白甲基化修饰与糖尿病肾病:潜在的分子机制和治疗方法(综述)。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5428. Epub 2024 Sep 20.
2
Inseparable RNA binding and chromatin modification activities of a nucleosome-interacting surface in EZH2.EZH2中一个核小体相互作用表面的不可分割的RNA结合和染色质修饰活性
Nat Genet. 2024 Jun;56(6):1193-1202. doi: 10.1038/s41588-024-01740-8. Epub 2024 May 14.
3
JMJD3 regulate H3K27me3 modification via interacting directly with TET1 to affect spermatogonia self-renewal and proliferation.JMJD3 通过与 TET1 直接相互作用来调节 H3K27me3 修饰,从而影响精原细胞自我更新和增殖。
BMC Genomics. 2024 Feb 29;25(1):225. doi: 10.1186/s12864-024-10120-9.
4
CK2-mediated phosphorylation of SUZ12 promotes PRC2 function by stabilizing enzyme active site.CK2 介导的 SUZ12 磷酸化通过稳定酶活性位点促进 PRC2 功能。
Nat Commun. 2022 Nov 9;13(1):6781. doi: 10.1038/s41467-022-34431-1.
5
LncRNA-Smad7 mediates cross-talk between Nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells.长链非编码 RNA-Smad7 介导 Nodal/TGF-β 和 BMP 信号之间的串扰,以调节多能和多潜能细胞的细胞命运决定。
Nucleic Acids Res. 2022 Oct 14;50(18):10526-10543. doi: 10.1093/nar/gkac780.
6
All Quiet on the TE Front? The Role of Chromatin in Transposable Element Silencing.TE 沉寂无声?染色质在转座元件沉默中的作用。
Cells. 2022 Aug 11;11(16):2501. doi: 10.3390/cells11162501.
7
PRC2, Chromatin Regulation, and Human Disease: Insights From Molecular Structure and Function.PRC2、染色质调控与人类疾病:来自分子结构与功能的见解
Front Oncol. 2022 Jun 21;12:894585. doi: 10.3389/fonc.2022.894585. eCollection 2022.
8
Context-specific Polycomb mechanisms in development.发育过程中具有特定背景的 Polycomb 机制。
Nat Rev Genet. 2022 Nov;23(11):680-695. doi: 10.1038/s41576-022-00499-0. Epub 2022 Jun 9.
9
Polycomb Repressive Complex 2 in Eukaryotes-An Evolutionary Perspective.真核生物中的多梳抑制复合物2——进化视角
Epigenomes. 2022 Jan 17;6(1):3. doi: 10.3390/epigenomes6010003.
10
PRC1 drives Polycomb-mediated gene repression by controlling transcription initiation and burst frequency.PRC1 通过控制转录起始和爆发频率来驱动 Polycomb 介导的基因抑制。
Nat Struct Mol Biol. 2021 Oct;28(10):811-824. doi: 10.1038/s41594-021-00661-y. Epub 2021 Oct 4.

本文引用的文献

1
Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms.EZH2基因的突变与骨髓肿瘤患者的不良预后相关。
Genes Dis. 2019 May 16;6(3):276-281. doi: 10.1016/j.gendis.2019.05.001. eCollection 2019 Sep.
2
EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression.EZH2通过表观遗传抑制miR-381表达促进乳腺癌顺铂耐药。
Onco Targets Ther. 2019 Nov 13;12:9627-9637. doi: 10.2147/OTT.S214104. eCollection 2019.
3
Clinical significance of USP7 and EZH2 in predicting prognosis of laryngeal squamous cell carcinoma and their possible functional mechanism.USP7和EZH2在预测喉鳞状细胞癌预后中的临床意义及其可能的功能机制
Int J Clin Exp Pathol. 2019 Jun 1;12(6):2184-2194. eCollection 2019.
4
Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.子宫内膜癌中增强子结合锌指蛋白 2(EZH2)的过表达:NRG 肿瘤学/妇科肿瘤学组研究。
Gynecol Oncol. 2020 Feb;156(2):423-429. doi: 10.1016/j.ygyno.2019.12.003. Epub 2019 Dec 13.
5
Prognostic Value of TWIST1 and EZH2 Expression in Colon Cancer.TWIST1和EZH2表达在结肠癌中的预后价值
J Gastrointest Cancer. 2021 Mar;52(1):90-98. doi: 10.1007/s12029-019-00344-4.
6
PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes.PRC2 复合物相关功能障碍与过度生长综合征:EZH2、EED 和 SUZ12 及其综合征表型的综述。
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):519-531. doi: 10.1002/ajmg.c.31754. Epub 2019 Nov 14.
7
p38α/S1P/SREBP2 activation by the SAM-competitive EZH2 inhibitor GSK343 limits its anticancer activity but creates a druggable vulnerability in hepatocellular carcinoma.SAM竞争性EZH2抑制剂GSK343对p38α/S1P/SREBP2的激活限制了其抗癌活性,但在肝细胞癌中产生了一个可药物靶向的弱点。
Am J Cancer Res. 2019 Oct 1;9(10):2120-2139. eCollection 2019.
8
Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and Progression.增强子结合锌指蛋白 2 在结直肠癌发生和发展中的作用。
Digestion. 2021;102(2):227-235. doi: 10.1159/000504093. Epub 2019 Nov 6.
9
GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells.GSK343可诱导胰腺癌细胞发生自噬并下调AKT/mTOR信号通路。
Exp Ther Med. 2019 Oct;18(4):2608-2616. doi: 10.3892/etm.2019.7845. Epub 2019 Aug 2.
10
PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.PRC2.1 和 PRC2.2 协同作用以协调 H3K27 三甲基化。
Mol Cell. 2019 Nov 7;76(3):437-452.e6. doi: 10.1016/j.molcel.2019.08.012. Epub 2019 Sep 11.

PRC2 介导的 H3K27 完全甲基化对于初始胚体形成不是必需的,但对于维持分化细胞的身份是必需的。

Full methylation of H3K27 by PRC2 is dispensable for initial embryoid body formation but required to maintain differentiated cell identity.

机构信息

Department of Molecular Biology, Massachusetts General Hospital Research Institute, Massachusetts General Hospital, Boston, MA 02114, USA.

Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Development. 2021 Apr 1;148(7). doi: 10.1242/dev.196329. Epub 2021 Apr 15.

DOI:10.1242/dev.196329
PMID:33688077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8077505/
Abstract

Polycomb repressive complex 2 (PRC2) catalyzes methylation of histone H3 on lysine 27 and is required for normal development of complex eukaryotes. The nature of that requirement is not clear. H3K27me3 is associated with repressed genes, but the modification is not sufficient to induce repression and, in some instances, is not required. We blocked full methylation of H3K27 with both a small molecule inhibitor, GSK343, and by introducing a point mutation into EZH2, the catalytic subunit of PRC2, in the mouse CJ7 cell line. Cells with substantively decreased H3K27 methylation differentiate into embryoid bodies, which contrasts with EZH2 null cells. PRC2 targets had varied requirements for H3K27me3, with a subset that maintained normal levels of repression in the absence of methylation. The primary cellular phenotype of blocked H3K27 methylation was an inability of altered cells to maintain a differentiated state when challenged. This phenotype was determined by H3K27 methylation in embryonic stem cells through the first 4 days of differentiation. Full H3K27 methylation therefore was not necessary for formation of differentiated cell states during embryoid body formation but was required to maintain a stable differentiated state.

摘要

多梳抑制复合物 2(PRC2)催化组蛋白 H3 赖氨酸 27 的甲基化,是真核生物正常发育所必需的。但这种需求的本质尚不清楚。H3K27me3 与被抑制的基因有关,但该修饰不足以诱导抑制,并且在某些情况下不需要。我们使用小分子抑制剂 GSK343 和在 CJ7 细胞系中引入 PRC2 的催化亚基 EZH2 的点突变,阻止 H3K27 的完全甲基化。H3K27 甲基化实质性降低的细胞分化为胚状体,这与 EZH2 缺失细胞形成对比。PRC2 的靶基因对 H3K27me3 的需求存在差异,其中一部分在没有甲基化的情况下仍保持正常的抑制水平。阻断 H3K27 甲基化的主要细胞表型是改变的细胞在受到挑战时无法维持分化状态。这种表型通过胚胎干细胞中的 H3K27 甲基化在分化的前 4 天决定。因此,在胚状体形成过程中,完全的 H3K27 甲基化对于形成分化的细胞状态不是必需的,但对于维持稳定的分化状态是必需的。